# Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects

> **NCT00694044** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 50 (actual)

## Conditions studied

- Healthy
- Non-Smoking

## Interventions

- **DRUG:** varenicline
- **DRUG:** varenicline
- **DRUG:** varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00694044
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2009-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694044, "Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00694044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*